Related Experiment Video
Updated: Mar 6, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Promising Therapeutic Strategies for Mesenchymal Stem Cell-Based Cardiovascular Regeneration: From Cell Priming to
Seung Taek Ji1, Hyunyun Kim1, Jisoo Yun1
1Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea.
Insights
Mesenchymal stem cells (MSCs) show promise for cardiovascular regeneration but have low survival rates. Strategies like cell priming and tissue engineering aim to enhance MSC efficacy for treating ischemic cardiovascular diseases.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Therapy
Background:
- Ischemic cardiovascular diseases are a leading cause of death globally.
- Adult stem cell therapies, particularly mesenchymal stem cells (MSCs), offer potential for cardiovascular regeneration due to their immunomodulatory and vascular repair capabilities.
- A significant challenge for MSC therapy is their low survival rate in ischemic environments.
Purpose of the Study:
- To review current clinical applications of MSCs in treating cardiovascular diseases.
- To highlight strategies for enhancing MSC therapeutic efficacy for cardiovascular regeneration.
- To explore cell priming and tissue engineering approaches for improving MSC survival and function.
Main Methods:
- Review of current literature on MSC-based cardiovascular regeneration.
- Analysis of strategies for improving MSC survival and longevity in vivo.
- Examination of cell priming techniques and tissue engineering approaches (scaffolds, 3D printing).
Main Results:
- Mesenchymal stem cells (MSCs) possess properties suitable for cardiovascular regeneration.
- Low survival rates of engrafted MSCs in ischemic lesions remain a critical limitation.
- Cell priming and advanced tissue engineering strategies show potential to overcome MSC limitations.
Conclusions:
- Mesenchymal stem cells (MSCs) are promising for cardiovascular regeneration but require enhanced therapeutic strategies.
- Priming MSCs and utilizing tissue engineering approaches like scaffolds and 3D printing can improve their efficacy.
- Further development in these areas is crucial for advancing MSC-based treatments for ischemic cardiovascular diseases.
Abstract:
The primary cause of death among chronic diseases worldwide is ischemic cardiovascular diseases, such as stroke and myocardial infarction. Recent evidence indicates that adult stem cell therapies involving cardiovascular regeneration represent promising strategies to treat cardiovascular diseases. Owing to their immunomodulatory properties and vascular repair capabilities, mesenchymal stem cells (MSCs) are strong candidate therapeutic stem cells for use in cardiovascular regeneration. However, major limitations must be overcome, including their very low survival rate in ischemic lesion. Various attempts have been made to improve the poor survival and longevity of engrafted MSCs. In order to develop novel therapeutic strategies, it is necessary to first identify stem cell modulators for intracellular signal triggering or niche activation. One promising therapeutic strategy is the priming of therapeutic MSCs with stem cell modulators before transplantation. Another is a tissue engineering-based therapeutic strategy involving a cell scaffold, a cell-protein-scaffold architecture made of biomaterials such as ECM or hydrogel, and cell patch- and 3D printing-based tissue engineering. This review focuses on the current clinical applications of MSCs for treating cardiovascular diseases and highlights several therapeutic strategies for promoting the therapeutic efficacy of MSCs in vitro or in vivo from cell priming to tissue engineering strategies, for use in cardiovascular regeneration.
More Related Videos
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Mesenchymal Stem Cells
Stem Cell Culture

